Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

PHASE3RecruitingINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

December 1, 2023

Study Completion Date

June 1, 2024

Conditions
Bladder Cancer
Interventions
DRUG

Alvimopan

To determine if Alvimopan during radical cystectomy with urinary diversion results in faster return of bowel function.

DRUG

Placebo

To determine if placebo during radical cystectomy with urinary diversion results in faster return of bowel function.

Trial Locations (1)

02115

RECRUITING

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Brigham and Women's Hospital

OTHER